A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2002
12/24/2002	US6497880 Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
12/24/2002	US6497879 Composition which comprises isolated mage-10 tumor rejection antigen precursor which is encoded by nucleic acid having specified nucleotide sequence
12/24/2002	CA2086264C Surface complexed lymphotoxin
12/24/2002	CA2070182C Chimeric immunoglobulin for cd4 receptors
12/24/2002	CA2065404C Assays and reagents for amyloid deposition
12/23/2002	WO2002094290A1 Use of lps for treating intestinal inflammation processes
12/23/2002	CA2414288A1 Use of lps in the treatment of intestinal inflammatory processes
12/19/2002	WO2002101412A2 Spray freeze-dried compositions
12/19/2002	WO2002101069A2 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002	WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002	WO2002101046A1 Monoclonal antibody binding to mt4-mmp catalytic domain
12/19/2002	WO2002101045A2 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002	WO2002101019A2 Methods of culturing animal cells and polypeptide production in animal cells
12/19/2002	WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002	WO2002101005A2 A g-protein coupled receptor and uses therefor
12/19/2002	WO2002100901A2 Determination of bone-sialoprotein in bodily fluids for oncological problems
12/19/2002	WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002	WO2002100891A2 Proteins derived from non-typable haemophilus influenzae (nthi) strain
12/19/2002	WO2002100889A1 Novel epitope of human papilloma virus e7 antigen and cd4-positive t cells activated by the epitope
12/19/2002	WO2002100836A2 Compounds, compositions and methods for modulating beta-amyloid production
12/19/2002	WO2002100431A1 A pharmaceutical kit comprising anti-human seminal plasma protein single chain antibody/human carboxypeptidase fusion protein and prodrug
12/19/2002	WO2002100430A1 Vaccine complex for preventing or treating leishmaniases
12/19/2002	WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
12/19/2002	WO2002100406A1 Use of yohimbine in the preparation of immunobiologically active drugs
12/19/2002	WO2002100348A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr)
12/19/2002	WO2002100345A2 Vaccines, immunotherapeutics and methods of using the same
12/19/2002	WO2002100343A2 N-terminally truncated galectin-3 and antibodies for treating cancer
12/19/2002	WO2002100340A2 Improved vaccination against anthrax
12/19/2002	WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002	WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
12/19/2002	WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels
12/19/2002	WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002	WO2002100317A2 Targeted particles and methods of using the same
12/19/2002	WO2002100148A2 Treatment or prophylaxis of insulin-producing cell graft rejection
12/19/2002	WO2002085937A3 Inflammation-specific peptides and the uses thereof
12/19/2002	WO2002082075A9 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
12/19/2002	WO2002080981A3 Polynucleotide binding complexes comprising sterols and saponins
12/19/2002	WO2002079475A3 Streptococcus pyogenes antigens and corresponding dna fragments
12/19/2002	WO2002076388A3 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
12/19/2002	WO2002074243A3 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
12/19/2002	WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002	WO2002066506A3 Use of casb7439 (ash2) in the immunotherapy of breast cancer
12/19/2002	WO2002062370A9 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
12/19/2002	WO2002058626A9 Methods and compositions for the identification and treatment of neurodegenerative disorders
12/19/2002	WO2002053176A3 An autologous anti-cancer vaccine
12/19/2002	WO2002053106A3 Autoantigen composition
12/19/2002	WO2002024727A3 New inhibitors of iapp fibril formation and uses thereof
12/19/2002	WO2002022825A3 The c. albicans tec1 gene (catec1) and the coded tec1p protein
12/19/2002	WO2002011767A3 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
12/19/2002	WO2002008287A3 Nk cells activating receptors and their therapeutic and diagnostic uses
12/19/2002	WO2001082788A9 Compounds and methods for the treatment and prevention of bacterial infection
12/19/2002	WO2001073026A9 43238, a novel g protein-coupled receptor and uses therefor
12/19/2002	WO2001070245A9 Immune mediators and related methods
12/19/2002	WO2001070032A9 Recombinant parainfluenza virus expression systems and vaccines
12/19/2002	WO2001068859A9 Il-17 receptor like molecules and uses thereof
12/19/2002	WO2001068679A9 Peptides targeting specifically tumor-derived endothelial cells
12/19/2002	WO2001004335A3 Human-bovine chimeric respiratory syncytial virus vaccines
12/19/2002	US20020194648 Plasmodium falciparum merozoite surface protein-1 malaria produced in transgenic plants
12/19/2002	US20020194633 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
12/19/2002	US20020194631 Method of treating psoriasis using anti-interleukin 12 antibody
12/19/2002	US20020193778 Method of intradermally injecting substances
12/19/2002	US20020193740 Method of intradermally injecting substances
12/19/2002	US20020193729 Microprojection array immunization patch and method
12/19/2002	US20020193572 Generation of glycosylated antibody; obtain cell, incubate with vector expressing preferential antibody, transfected with a vector, propagate, express vector, recover antibody
12/19/2002	US20020193571 Wsx receptor agonist antibodies
12/19/2002	US20020193565 Antigen preparation and use
12/19/2002	US20020193416 Synergistic tumorcidal response induced by histamine
12/19/2002	US20020193333 For immunization for the therapy of diseases with or without combination chemotherapy
12/19/2002	US20020193330 Genetically engineered co-expression DNA vaccines, construction methods and uses thereof
12/19/2002	US20020193329 Useful as vaccines
12/19/2002	US20020193326 Methods of inhibiting proliferative diseases
12/19/2002	US20020193309 Contacting the sample or tissue with fibroblast growth factor 9 (FGF9) and allowing formation of receptor-ligand pairs; detecting presence of FGFR3-FGF9 pairs, a positive detection indicating presence of FGFR3 in the sample or tissue
12/19/2002	US20020193306 Treatment of allergic rhinitis
12/19/2002	US20020193304 Anti-HIV agents
12/19/2002	US20020193296 Vaccines; therapy; prophylaxis
12/19/2002	US20020193295 Immunogenic peptides and uses thereof
12/19/2002	US20020193288 Methods of treating hypertension and compositions for use therein
12/19/2002	US20020192825 Methods of use of viral vectors to deliver antigen to dendritic cells
12/19/2002	US20020192822 Herpes simplex virus ICP4 is an inhibitor of apoptosis
12/19/2002	US20020192814 Colloidal metal compositions and methods
12/19/2002	US20020192781 Desaturase antigen of mycobacterium tuberculosis
12/19/2002	US20020192764 Anti-paratopic antibody as an immunogen
12/19/2002	US20020192763 Compositions and methods for the therapy and diagnosis of prostate cancer
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192752 Compositions and methods for the treatment of immune related diseases
12/19/2002	US20020192729 Apoptosis protein for use in the diagnosis and treatment of cell proliferative disorders
12/19/2002	US20020192706 Nucleotide sequences coding polypeptides for use treatment of cell proliferation disorders
12/19/2002	US20020192695 Detection of modulator of tumor suppressor activity; obtain sample of polypeptide, incubate with modulator, monitor adjustment in polypeptide activity
12/19/2002	US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002	US20020192681 Detection of parasite in sample; obtain sample, isolate nucleotide sequences from dendritic cells, determine gene expression, presence of preferential gene indicates infections
12/19/2002	US20020192672 Cell culture for use in the detection of ehrlichia infections
12/19/2002	US20020192666 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer
12/19/2002	US20020192660 Reducing effect of regulatory sequences on transcription; obtain nucleotide sequences, detect regulatory sequences, mutate, transfect into cell, culture, monitor adjustment in transcription control
12/19/2002	US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002	US20020192276 Use of G class immunoglobulins for the topical treatment of atopic dermatitis
12/19/2002	US20020192275 Liposome composition for improved intracellular delivery of a therapeutic agent
12/19/2002	US20020192264 Materials and methods for the treatment or prevention of obesity

1 ... 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 ... 1823